Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

RxSight (RXST) Interest Expenses (2020 - 2026)

RxSight filings provide 6 years of Interest Expenses readings, the most recent being $5000.0 for Q4 2025.

  • On a quarterly basis, Interest Expenses changed 0.0% to $5000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $20000.0, a 9.09% decrease, with the full-year FY2025 number at $19000.0, down 9.52% from a year prior.
  • Interest Expenses hit $5000.0 in Q4 2025 for RxSight, up from $4000.0 in the prior quarter.
  • In the past five years, Interest Expenses ranged from a high of $1.6 million in Q2 2023 to a low of $4000.0 in Q4 2023.
  • Median Interest Expenses over the past 5 years was $464000.0 (2021), compared with a mean of $598950.0.
  • Biggest five-year swings in Interest Expenses: skyrocketed 35866.67% in 2021 and later crashed 99.72% in 2023.
  • RxSight's Interest Expenses stood at $1.1 million in 2021, then surged by 34.48% to $1.5 million in 2022, then tumbled by 99.72% to $4000.0 in 2023, then increased by 25.0% to $5000.0 in 2024, then changed by 0.0% to $5000.0 in 2025.
  • The last three reported values for Interest Expenses were $5000.0 (Q4 2025), $4000.0 (Q3 2025), and $5000.0 (Q2 2025) per Business Quant data.